Related Experiment Video
Updated: Feb 17, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Thrombolysis after acute myocardial infarction
Insights
Thrombolysis offers significant benefits for acute myocardial infarction patients with classic symptoms. This treatment has limited risks and can be safely given to a broader patient population than currently realized.
Area of Science:
- Cardiology
- Emergency Medicine
- Pharmacology
Background:
- Thrombolysis is a proven treatment for acute myocardial infarction (AMI).
- Physician awareness of the expanded patient eligibility and low risk profile of thrombolysis may be limited.
- Current treatment rates for eligible AMI patients may be suboptimal.
Purpose of the Study:
- To review current indications and contraindications for thrombolysis in AMI.
- To summarize clinical trial data comparing available thrombolytic agents.
- To advocate for broader application of thrombolysis in eligible AMI patients.
Main Methods:
- Literature review of major clinical studies.
- Analysis of data on thrombolytic agents, efficacy, and safety.
- Synthesis of current guidelines regarding thrombolysis in AMI.
Main Results:
- Thrombolysis demonstrates significant benefits in specific AMI patient cohorts.
- The risks associated with thrombolysis are relatively limited.
- A substantial number of AMI patients who could benefit from thrombolysis are not currently receiving it.
Conclusions:
- Thrombolysis is underutilized in acute myocardial infarction management.
- Expanded patient selection criteria and risk-benefit understanding can increase thrombolysis administration.
- Further education on thrombolytic therapy is warranted for healthcare providers.
Abstract:
Preview Physicians know that thrombolysis has marked benefits in patients with certain classic findings after acute myocardial infarction. However, some do not realize that thrombolysis has relatively limited risks and can be administered to many more patients than it is at present. The authors review current indications and contraindications and summarize results of major clinical studies that compare currently available thrombolytic agents.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Anticoagulant Drugs: Low-Molecular-Weight Heparins

